Caladrius Biosciences
Data Breaches, Cyber Attacks and Security Report

https://caladrius.com  ᛫  Biotech & Pharmaceuticals
Last updated September 21, 2019

About Caladrius Biosciences

Company Overview

Caladrius Biosciences (NASDAQ: CLBS) is an American biopharmaceutical company active in the field of stem cell therapy and regenerative medicine, particularly (in 2012) of cardiovascular disease. The company was founded in 1980 and was formerly known as Corniche Group Inc, Phase III Medical Inc and NeoStem, Inc.

Valuation

Employees

CEO

David J. Mazzo

Location

Data Breaches and Security News

Caladrius Biosciences Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Caladrius Biosciences is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Caladrius Biosciences

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Caladrius Biosciences's security performance with other companies